8/16/2019 Immunological Off-target Effects of Imatinib

1/16

http://dx.doi.org/10.1038/nrclinonc.2016.41mailto:kroemer@orange.frmailto:laurence.zitvogel@gustaveroussy.frmailto:laurence.zitvogel@gustaveroussy.fr

8/16/2019 Immunological Off-target Effects of Imatinib

2/16

8/16/2019 Immunological Off-target Effects of Imatinib

3/16

8/16/2019 Immunological Off-target Effects of Imatinib

4/16

8/16/2019 Immunological Off-target Effects of Imatinib

5/16

8/16/2019 Immunological Off-target Effects of Imatinib

6/16

8/16/2019 Immunological Off-target Effects of Imatinib

7/16

8/16/2019 Immunological Off-target Effects of Imatinib

8/16

8/16/2019 Immunological Off-target Effects of Imatinib

9/16

8/16/2019 Immunological Off-target Effects of Imatinib

10/16

8/16/2019 Immunological Off-target Effects of Imatinib

11/16

8/16/2019 Immunological Off-target Effects of Imatinib

12/16

8/16/2019 Immunological Off-target Effects of Imatinib

13/16

8/16/2019 Immunological Off-target Effects of Imatinib

14/16

8/16/2019 Immunological Off-target Effects of Imatinib

15/16

https://clinicaltrials.gov/ct2/show/NCT01738139https://clinicaltrials.gov/ct2/show/NCT01738139https://clinicaltrials.gov/ct2/show/NCT01643278https://clinicaltrials.gov/ct2/show/NCT01643278https://clinicaltrials.gov/ct2/show/NCT02011945https://clinicaltrials.gov/ct2/show/NCT02011945

8/16/2019 Immunological Off-target Effects of Imatinib

16/16